As of 2023, actual hospital discharges for malignant neoplasm of the bladder in France stood at a value of approximately 51.6 thousand. The forecast from 2024 to 2028 shows a steady increase in hospital discharges, rising from 52.1 thousand in 2024 to 54.06 thousand by 2028, representing a consistent year-on-year escalation. The year-on-year growth percentages are modest, with the compounded annual growth rate (CAGR) over these five years indicating a gradual yet steady upward trend.
Future trends to watch for:
- Potential impacts of advancements in early detection and treatment could affect discharge rates.
- Demographic shifts, such as an aging population, may contribute to increased discharge rates.
- Healthcare policy changes and resource allocation might influence the availability of hospital care for bladder cancer.
